Thursday ،Jan 27, 2022، 12:13


MPO's managing director makes unannounced visit to IRCS' Central Pharmacy
In his unannounced visit to IRCS' Central Pharmay, Dr. Askari stressed that: We have endeavored in order to improve the quality of services we render
22 January 2022
Joint meeting held between MPO's managing director, acting manager of Helal Iran pharmaceutical and clinical complex
With the aim to expand bilateral cooperation and interaction, the joint meeting was held in presence of Dr. Alireza Askari and Dr. Shahrokh Ramin
15 January 2022
MPO's medical devices unit supplies, distributes chemotherapy ports
MPO's medical devices unit has made chemotherapy ports available to patients with cancer and ostomy
8 January 2022
Soha Pharmaceutical Co. manufactured more than 25m pharmaceutical items
Soha Pharmaceutical Co. has done its utmost to reduce demands by developing its activities in manufacturing human medicines
1 January 2022
Page 1 From 13

Medicine News

WHO has recommended two new drugs for COVID-19, providing yet more options for treating the disease. The extent to which these medicines will save lives depends on how widely available and affordable they will be.
On 26 November 2021, WHO designated the variant B.1.1.529 a variant of concern, named Omicron, on the advice of WHO’s Technical Advisory Group on Virus Evolution (TAG-VE). This decision was based on the evidence presented to the TAG-VE that Omicron has several mutations that may have an impact on how it behaves, for example, on how easily it spreads or the severity of illness it causes. Here is a summary of what is currently known.
WHO lists 9th COVID-19 vaccine for emergency use with aim to increase access to vaccination in lower-income countries
The top 10 causes of death
Page 1 From 7

Photo Gallery

نقشه جدید